Onkologie. 2009:3(4):242-246

Some aspects of combined treatment of pelvic tumors

Jan Žaloudík
Masarykův onkologický ústav - oddělení chirurgické onkologie, Brno

Carcinomas of pelvic organs together with two hundreds of pelvic sarcomas represent annually almost 15,000 new oncological cases

in the Czech Republic, which is 30 % of all life-threatening malignancies. Despite of subdivision of this field among abdominal surgery,

gastronterology, gynaecological and urological oncology, solution of many problems must be based on multidisciplinary co-operation,

especially in advanced and complicated cases. Integrated approach is required by endoscopic, imaging and laboratory diagnostic

methods as well as by treatment, which includes surgery, radiotherapy and chemotherapy. Important and often underestimated topics

include urinary and bowel derivation, but also prophylaxis and proper solutions of other pelvic complications. Because it is unlikely

that pelvic oncology will ever be an independent specialisation, it is necessary to organize concerted multidisciplinary co-operation for

pelvic tumors especially in comprehensive cancer centers. This paper summarizes main aspects, requirements and problems associated

with this kind of co-operation.

Keywords: malignant tumors of pelvis, multidisciplinary approach, combined treatment.

Published: November 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žaloudík J. Some aspects of combined treatment of pelvic tumors. Onkologie. 2009;3(4):242-246.
Download citation

References

  1. Ang C, Naik R. The value of ureteric stents in debulking surgery for disseminated ovarian cancer. Int J Gynecol Cancer. 2009 Jul; 19(5): 978-980. Go to original source... Go to PubMed...
  2. Ciorba MA, Stenson WF. Probiotic therapy in radiationinduced intestinal injury and repair. Ann N Y Acad Sci. 2009 May; 1165: 190-194. Go to original source... Go to PubMed...
  3. Kubecová M, Horák L, Kohout P, Granátová J. Changes in small intestine permeability after radiotherapy of malignant tumor. Hepatogastroenterology. 2008 Mar-Apr; 55(82-83): 463-466. Go to original source... Go to PubMed...
  4. Milliat F, Jullien N, Blirando K, Abderrahmani R, Benderitter M. Radiotherapy: what therapeutic orientations against the digestive aftereffects? Med Sci (Paris). 2009 Mar; 25(3): 267-272. Go to original source... Go to PubMed...
  5. Klerkx WM, Heintz AP, Mali WP, de Kort GA, Takahara T, van Dorst EB, Peeters PH. Lymph node detection by MRI before and after a systematic pelvic lymphadenectomy. Gynecol Oncol. 2009 Aug; 114(2): 315-318. Go to original source... Go to PubMed...
  6. Inoue K, Sato T, Kitamura H, Hirayama A, Kurosawa H, Tanaka T, Fukushi M, Moriyama N, Fujii H. An anthropomorphic pelvis phantom for optimization of the diagnosis of lymph node metastases in the pelvis. Ann Nucl Med. 2009 May; 23(3): 245-255. Go to original source... Go to PubMed...
  7. Thoeny HC, Binser T, Roth B, Kessler TM, Vermathen P. Noninvasive Assessment of Acute Ureteral Obstruction with Diffusion-weighted MR Imaging: A Prospective Study. Radiology. 2009 Jun 30 (E-publ ahead of print). Go to original source... Go to PubMed...
  8. Ren J, Huan Y, Wang H, Ge Y, Chang Y, Yin H, Sun L. Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol. 2009 Jun 10. (E-publ ahead of print). Go to original source... Go to PubMed...
  9. Léautaud A, Marcus C, Ben Salem D, Bouché O, Graesslin O, Hoeffel C. Pelvic MRI at 3.0 Tesla. Radiol. 2009 Mar; 90 (3 Pt 1): 277-286. Go to original source... Go to PubMed...
  10. Thomassin-Naggara I, Dara? E, Cuenod CA, Fournier L, Toussaint I, Marsault C, Bazot M. Contribution of diffusionweighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol. 2009; 19(6): 1544-1552. Go to original source... Go to PubMed...
  11. Fader AN, Escobar PF. Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: technique and initial report. Gynecol Oncol 2009; 114(2): 157-161. Go to original source... Go to PubMed...
  12. Tytherleigh MG, Warren BF, Mortensen NJ. Management of early rectal cancer. Br J Surg. 2008; 95(9): 1189-1190. Go to original source... Go to PubMed...
  13. Hofheinz RD, Hartel M, Kaehler GF, Neff W, Diehl SJ. Preoperative staging of rectal tumors: comparison of endorectal ultrasound, hydro-CT, and high-resolution endorectal MRI. Onkologie 2008; 31(5): 230-235. Go to original source... Go to PubMed...
  14. Peiffert D, Bey P, Pernot M, Hoffstetter S, Marchal C, Beckendorf V, Guillemin F. Conservative treatment by irradiation of epidermoid carcinomas of the anal margin. Int J Radiat Oncol Biol Phys. 1997; 1, 39(1): 57-66. Go to original source... Go to PubMed...
  15. Choi MH, Hong DG, Seong WJ, Lee YS, Park IS. Pelvic actinomycosis confirmed after surgery: single center experience. Arch Gynecol Obstet. 2009 Jun 30. (Epub ahead of print). Go to original source... Go to PubMed...
  16. Heidrich H, Konau E, Hesse P. Asymptomatic venous thrombosis in cancer patients - a problem often overlooked. Results of a retrospective and prospective study. Vasa. 2009; 38(2): 160-166. Go to original source... Go to PubMed...
  17. Georgescu ES, Goldberg JM, du Plessis SS, Agarwal A. Present and future fertility preservation strategies for female cancer patients. Obstet Gynecol Surv. 2008; 63(11): 725-732. Go to original source... Go to PubMed...
  18. Bristow RE, Peiretti M, Gerardi M, Zanagnolo V, Ueda S, Diaz-Montes T, Giuntoli RL 2nd, Maggioni A. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome. Gynecol Oncol 2009; 114(2): 173-177. Go to original source... Go to PubMed...
  19. Fowler JM. Incorporating pelvic/vaginal reconstruction into radical pelvic surgery. Gynecol Oncol 2009; 9. (E-publ ahead of print). Go to original source... Go to PubMed...
  20. Yoshioka J. Current status and perspectives of brachytherapy for prostate cancer. Int J Clin Oncol 2009; 14(1): 31-36. Go to original source... Go to PubMed...
  21. Devic S, Vuong T, Moftah B, Evans M, Podgorsak EB, Poon E, Verhaegen F. Image-guided high dose rate endorectal brachytherapy. Med Phys 2007; 34(11): 4451-4458. Go to original source... Go to PubMed...
  22. Muacevic A, Drexler C, Kufeld M, Romanelli P, Duerr HJ, Wowra B. Fiducial-free real-time image-guided robotic radiosurgery for tumors of the sacrum/pelvis. Radiother Oncol 2009 Jun 22 (Epub ahead of print). Go to original source... Go to PubMed...
  23. Zafrakas M, Papanikolaou AN, Venizelos ID, Kellartzis D, Agorastos T, Bontis JN. A rare case of renal cell carcinoma metastasizing to the uterine cervix. Eur J Gynaecol Oncol 2009; 30(2): 239-240. Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.